Priority actions for the non-communicable disease crisis

Grants

Funding Acknowledgements

PA has received grants from Wellcome Trust Clinical PhD Fellowship. SE has received grants from the Wellcome Trust, and royalties from 18 McGraw Hill for editing a book. RI-I is the editor of The Lancet. TG has received consultancy payments from Family Health International and 19 Inter-American Development Bank; and payment for lectures, including lectures on speakers bureaus, from Network for Continuing Medical 20 Education. BN has received consultancy payments from Bayer, payment for lectures including service on speakers bureaus from Allergan, and 21 royalties for a book published by Karolinska University Press. BN's institute has received money for consultancy from Syngis, Servier, Bayer, 22 Photothera, and Boehringer-Ingelheim. JT has received or has grants pending from Corporate Partners, Pfizer, Wiley, Sanofi-Aventis, Varian Medical Systems, Roche, Boehringer Ingelheim, Novartis, Slender, 23 Merck, Eli Lilly, Heng Rui, and Irmet. The other authors declare that they have no conflicts of interest.We thank the National Heart Forum for providing financial, technical, and administrative support for the production of this report. The authors alone are responsible for the views expressed in this report and they do not necessarily represent the decisions, policy, or views of WHO, the World Bank, the OECD, or those of the member countries of these organisations.